Tanja Rudolph

Tanja Rudolph

Interventional cardiologist / Cardiologist
Heart and Diabetes Center NRW - Bad Oeynhausen, Germany

Latest contributions

Challenges in treating tricuspid regurgitation

22 May 2026 – From EuroPCR 2026

This session addresses the complexities of treating tricuspid regurgitation, offering insights into tailored treatment options and complication management. Through detailed case studies from China and Germany, it highlights practical approaches and bailout strategies for tricuspid valve interventions.

Active unloading with Impella heart pumps in elective and emergent patients

21 May 2026 – From EuroPCR 2026

This session presents the latest evidence on the use of microaxial Impella heart pumps in both elective high-risk and emergent cardiogenic shock patients. It highlights the importance of organised systems of care in improving survival outcomes and explores current data and expert consensus on mechanical circulatory...

Active unloading with Impella heart pumps in elective and emergent patients

Advancing TAVI practice

21 May 2026 – From EuroPCR 2026

Advancing TAVI practice is the focus of this session, addressing antiplatelet therapy choices, novel transcatheter treatments for pure aortic regurgitation, early hemodynamic valve deterioration as a prognostic marker, prosthesis-patient mismatch in redo-TAVI, pioneering valve-in-mechanical valve interventions, and comprehensive core-lab evaluation of implantation depth and clinical outcomes.

Antithrombotic therapy after TAVI: optimal agents, regimens, and patient selection

20 May 2026 – From EuroPCR 2026

This session critically evaluates antithrombotic therapy following TAVI, addressing optimal agents and regimens tailored to patients with and without atrial fibrillation. It also reviews clinical presentations and management of valve thrombosis post-TAVI, using guideline-based approaches and real-world cases to individualize patient care.

Antithrombotic therapy after TAVI: optimal agents, regimens, and patient selection

Advancing mitral care with the Intrepid TMVR system

20 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session explores the Intrepid transcatheter mitral valve replacement (TMVR) system and its role in expanding treatment options for patients with mitral regurgitation, including complex anatomies such as mitral annular calcification (MAC).

It highlights how the system’s design features and procedural imaging support a streamlined...

Advancing mitral care with the Intrepid TMVR system

New frontiers: TAVI for aortic regurgitation with conventional and dedicated devices

20 May 2026 – From EuroPCR 2026

This session explores new frontiers in transcatheter aortic valve implantation (TAVI) for treating pure aortic regurgitation. It addresses the challenges inherent to this indication, reviews treatment approaches using conventional balloon-expandable and self-expandable devices, and presents recent data along with dedicated TAVI devices designed specifically for aortic...

Evidence base: current data on TAVI durability and long-term outcomes

28 Apr 2026

This article reviews the current evidence on TAVI durability, focusing on long-term outcomes, device-specific considerations, and the implications for lifetime management strategies.

Tanja Rudolph

Author

Tanja Rudolph
Georges El Hachem

Author

Georges El Hachem

All about PCR’s Teaching Assessment Board (TAB)

03 Dec 2025

Learn how session feedback is compiled to create a virtuous cycle of continuous refinement for education in #interventionalcardiology

TAVI in 2025: transforming care with the new valvular heart disease guidelines

18 Nov 2025 – From PCR London Valves 2025

This session explores how the 2025 valvular heart disease guidelines are transforming the landscape of TAVI care and clinical decision-making. It highlights the paradigm shift in managing severe aortic stenosis and provides a global perspective on the challenges and strategies for managing an expanding TAVI patient...

TAVI in 2025: transforming care with the new valvular heart disease guidelines

Hot topics in structural heart: addressing patients' unmet needs with EVOQUE TTVR and SAPIEN THV-in-THV

17 Nov 2025 – From PCR London Valves 2025

This session addresses emerging topics in structural heart disease by examining patient-centered solutions such as EVOQUE transcatheter tricuspid valve replacement (TTVR) and SAPIEN transcatheter heart valve-in-heart valve (THV-in-THV) procedures. It covers the latest data from Europe on redo TAVI, lifetime management strategies beginning with initial prosthesis...

Hot topics in structural heart: addressing patients' unmet needs with EVOQUE TTVR and SAPIEN THV-in-THV

Advancing structural heart with 3D ICE and device guidance

17 Nov 2025 – From PCR London Valves 2025

This PCR London Valves 2025 session explores how 3D TEE, 3D intracardiac echocardiography (ICE), and DeviceGuide technology sharpen procedural accuracy, strengthen operator confidence, and streamline decision-making in real time.

You’ll see how clearly defined team roles enhance both safety and efficiency, and how thoughtful workflow integration can reduce...

Advancing structural heart with 3D ICE and device guidance

How to approach the challenges of large annuli in TAVI

08 Sep 2025

Watch the replay of this webinar with T. Rudolph, D. Buckert and A. Schäfer to learn how to implement lifetime management in treating patients with large annuli and so much more!

Redo TAVI - How to treat different TAVI platforms when they fail

22 May 2025 – From EuroPCR 2025

Understand the complexities of redo TAVI procedures with emphasis on planning, valve platform characteristics, and tailored procedural strategies. This session features cases of redo TAVI for failed short-frame and tall-frame valves, alongside discussions on current evidence gaps guiding optimal management.

Redo TAVI - How to treat different TAVI platforms when they fail

Valve choice - Shaping index procedures and lifetime patient management

22 May 2025 – From EuroPCR 2025

This session addresses recent advancements and ongoing challenges in transcatheter aortic valve implantation (TAVI), with a particular focus on valve selection during index procedures. Presentations include data from the Accurate IDE trial, highlighting the prognostic implications of valve underexpansion. A clinical case involving an 80-year-old patient with severe...

Valve choice - Shaping index procedures and lifetime patient management

Hotline TAVI 3: Challenging anatomical and clinical scenarios

22 May 2025 – From EuroPCR 2025

This hotline session presents challenging anatomical and clinical scenarios in TAVI, including outcomes in bicuspid aortic valve patients, chronic aortic regurgigation, comparisons of surgical versus percutaneous approaches, and real-world data on valve performance and resource utilization.

Inludes:

  • Five-year outcomes from the Evolut low risk TAVR bicuspid study
  • Surgical versus...
Hotline TAVI 3: Challenging anatomical and clinical scenarios

What did we learn from my TAVI complications?

22 May 2025 – From EuroPCR 2025

Review critical lessons from TAVI complications, focusing on early identification and management of access site issues and acute coronary obstruction. Learn effective preventive actions and procedural strategies to minimize severe TAVI-related complications through detailed case discussions.

What did we learn from my TAVI complications?

TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation

22 May 2025 – From EuroPCR 2025

Address challenging TAVI scenarios involving bicuspid anatomy and pure aortic regurgitation with insights from international experiences. This session compares treatment options in China and Germany, explores anatomical and disease differences, and reviews various TAVI devices through detailed case presentations and expert commentary.

TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation

Novel devices for edge-to-edge mitral repair

21 May 2025 – From EuroPCR 2025

Discover novel devices advancing transcatheter edge-to-edge mitral valve repair (TEER). This session presents clinical experiences with cost-effective and uniquely designed TEER systems for patients with degenerative mitral regurgitation and heart failure, including first-in-man applications and case series demonstrating safety and efficacy.

Novel devices for edge-to-edge mitral repair

Hotline TAVI 1: extended analysis of the randomised trials

21 May 2025 – From EuroPCR 2025

Gain comprehensive insights from extended analyses of randomized TAVI trials. This session reviews five-year UK TAVI outcomes, cardiac damage evolution in asymptomatic aortic stenosis, one-year results from the LANDMARK trial, and three-year comparisons of balloon-expandable valves, highlighting critical clinical implications.

Hotline TAVI 1: extended analysis of the randomised trials

Full physiology: why and how to assess beyond coronary epicardial disease

20 May 2025 – From EuroPCR 2025

Understanding full coronary physiology is key to improving patient care. This EuroPCR 2025 session unpacks the concept and shows how to apply it easily in everyday clinical settings. Explore the latest ESC guidelines for managing patients with angina and no obstructive coronary artery disease (ANOCA), supported...

Full physiology: why and how to assess beyond coronary epicardial disease

Redo TAVI: how to treat different TAVI platforms when they fail?

22 May 2025 – From EuroPCR 2025

In this discussion, Tanja Rudolph, Dan Blackman, and Radoslaw Parma take a deep dive into the current understanding of redo TAVR.

Together, they address the main challenges faced in repeat procedures - chiefly, the risk of coronary obstruction and the importance of preserving coronary access, alongside strategies...

Redo TAVI: how to treat different TAVI platforms when they fail?

Valvular and structural interventions

16 May 2024 – From EuroPCR 2024

This session features presentations and discussions on various novel transcatheter technologies for valvular and structural heart interventions. It includes a novel transcatheter tricuspid repair technology, a new endovascular aortic root and total arch stent-graft replacement system, a novel self-expandable transcatheter aortic valve, and a transcatheter mitral...

Valvular and structural interventions

Expanding the heart team - Improved TAVI outcomes through pre-and post-procedure collaboration

16 May 2024 – From EuroPCR 2024

In this session, learn how to advance heart team collaboration through optimized TAVI pre-work-up and refined severe aortic stenosis patient selection, ensuring accurate intervention indications. Gain hands-on insights for effective post-TAVI strategies, explore procedural and valve refinements that simplify post-TAVI PCI, and stay informed on the...

Expanding the heart team - Improved TAVI outcomes through pre-and post-procedure collaboration

TAVI in challenging anatomies

14 May 2024 – From EuroPCR 2024

Explore the complexities of TAVI in patients with intricate aortic stenosis: learn the critical role of detailed CT imaging and meticulous pre-procedural planning, and find out how to customize valve selection and implantation techniques to match unique patient anatomies, such as highly calcified tricuspid valves, low...

TAVI in challenging anatomies

Mitral valve intervention in complex scenarios - Transcatheter mitral valve replacement - who are the eligible patients, and what are the available options?

21 Nov 2023 – From PCR London Valves 2023

This PCR London Valves 2023 session about mitral valve interventions seeks to address three key questions: identifying the ideal patient for Transcatheter Mitral Valve Implantation (TMVI), exploring treatment alternatives for ineligible patients, and discussing the prediction and management of left ventricular outflow tract obstruction. Watch video...

Mitral valve intervention in complex scenarios - Transcatheter mitral valve replacement - who are the eligible patients, and what are the available options?

Aortic regurgitation - Part 2

21 Nov 2023 – From PCR London Valves 2023

Dive into this session on aortic regurgitation to uncover the promising short-term outcomes of managing aortic regurgitation in patients with LVADs using a specialized TAVI device, to gain insights from an intermodal assessment approach utilizing both cardiac CT and MRI to evaluate the severity of aortic...

Aortic regurgitation - Part 2

PCR London Valves 2023 EAPCI Awards Ceremony

21 Nov 2023 – From PCR London Valves 2023

Discover the winners of the EAPCI Awards in this ceremony jointly presented by Emanuele Barbato, EAPCI President, and Tanja Rudolph, Co-Chair of the EAPCI Fellowship Grants Committee. While 14 nominees were shortlisted, seven had already been honored at EuroPCR 2023: Find out who the lucky winners...

EAPCI Awards Ceremony

Key questions in aortic valve intervention - What are the surgical and transcatheter treatment options for patients with severe aortic regurgitation?

21 Nov 2023 – From PCR London Valves 2023

Although aortic regurgitation is highly prevalent, it remains under-diagnosed and under-treated. Fortunately, the latest devices should rapidly reverse this trend, both surgically and through transcatheter treatments. Find out more about the options available today, whether surgical or transcatheter, with their benefits and limitations, and how to choose them...

Key questions in aortic valve intervention - What are the surgical and transcatheter treatment options for patients with severe aortic regurgitation?

Mitral edge-to-edge repair using advanced imaging techniques

20 Nov 2023 – From PCR London Valves 2023

Tricuspid valve intervention in complex scenarios - Patient and procedural optimisation

20 Nov 2023 – From PCR London Valves 2023

Watch this session to enhance your knowledge on optimizing patients throughout the entire transcatheter tricuspid valve intervention process— from pre-procedure preparation to post-procedural care. Learn effective strategies for managing immediate and early complications, refine post-procedural treatment plans, and gain insights into future strategies aimed at further...

Tricuspid valve intervention in complex scenarios - Patient and procedural optimisation